A Research Study of a New Medicine NNC0363-1063 in Healthy Participants and Participants With Type 1 Diabetes

NCT06685185 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

117

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG: NNC0363-1063
DRUG: Placebo
DRUG: Insulin degludec
DRUG: Insulin detemir

Sponsor

Novo Nordisk A/S